Healthcare -
Biotechnology - NASDAQ - US
$ 20.72
-1.57 %
$ 1.8 B
Market Cap
-4.58
P/E
TVTX - OPERATING EXPENSES
Operating Expenses TVTX - Travere Therapeutics, Inc.
522 M
LAST VALUE
20.37%
2 YEAR CAGR
18.08%
5 YEAR CAGR
36.08%
10 YEAR CAGR